Psychiatry AtlasMedication guide · United States

Antiseizure medicine; Equetro also treats bipolar mania

Carbamazepine (Equetro, Tegretol, Tegretol-XR)

Generic name
carbamazepine
Brand names
Equetro; Tegretol; Tegretol-XR
Medication class
Antiseizure medicine; Equetro also treats bipolar mania
Forms covered
Equetro extended-release capsules; Tegretol immediate-release tablets; Tegretol-XR extended-release tablets; Tegretol oral suspension

Article updated: 2026-10-24 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

  • carbamazepine can be confused with oxcarbazepine.
  • Tegretol can be confused with Tegretol XR (U.S. official label). These are different release formulations of the same active medication; their names must not be treated as interchangeable.
  • Tegretol can be confused with Tequin. Discontinued US systemic gatifloxacin product.
Show more (1)
  • Tegretol can be confused with Trental.

High Alert

  • Community/ambulatory care: dosing and product-selection errors can cause serious toxicity. Check the exact formulation and prescribed schedule.

FDA Boxed Warning

Equetro extended-release capsules; Tegretol immediate-release tablets; Tegretol-XR extended-release tablets; Tegretol oral suspension.

Potentially fatal skin reactions, including Stevens–Johnson syndrome and toxic epidermal necrolysis, and serious blood disorders, including aplastic anemia and agranulocytosis, can occur. Test for HLA-B*1502 before treatment in genetically at-risk patients; a positive result generally means avoiding treatment unless benefit clearly outweighs risk. Baseline blood counts and ongoing clinical monitoring are needed.

Carbamazepine treats selected seizures and trigeminal neuralgia. Equetro is also approved for acute bipolar I mania or mixed episodes; genetic skin-reaction risks and extensive interactions require careful screening.

What to expect: Benefit depends on the target: seizures, trigeminal nerve pain or acute bipolar mania with Equetro.

Warning signs · Medicine forms
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Acute manic or mixed episodes in bipolar I disorder — Adults. Product-specific approval; pediatric bipolar efficacy not established.Equetro extended-release capsules.
  • Specified seizure disorders and trigeminal neuralgia — Age and indication-specific populations. Not absence-seizure treatment; pediatric pain indications differ.Equetro extended-release capsules; Tegretol immediate-release tablets; Tegretol-XR extended-release tablets; Tegretol oral suspension.

What should I expect?

Benefit depends on the target: seizures, trigeminal nerve pain or acute bipolar mania with Equetro. Dose adjustments and follow-up are usually needed; dizziness or double vision can occur early.

Keep appointments for blood tests and review of symptoms. Contact the team promptly for a new rash, mouth sores, fever or unusual bruising.

How do I take it safely?

Instructions depend on the product. Equetro capsules may be swallowed whole or opened and all beads sprinkled on soft food without chewing; food is optional. Tegretol-XR must stay intact. Shake suspension, measure with an oral dosing device and do not mix or simultaneously administer it with other liquid medicines or diluents.

Before starting, discuss the indicated genetic skin-reaction testing, blood counts and liver tests. Follow sodium, symptoms and drug levels when needed. A negative genetic result does not rule out a dangerous rash. Existing bone-marrow suppression and recent MAOI use are important contraindications.

Check every prescription and supplement for interactions. Carbamazepine can reduce hormonal contraception effectiveness; discuss a reliable alternative or additional method. Avoid grapefruit and alcohol. Pregnancy can involve fetal harm, and breastfeeding needs a clinician’s assessment.

Do not stop abruptly or restart after repeated missed doses without advice. For an isolated missed dose, take it when remembered unless the next is near; never double. A new rash, fever, mouth sores or unusual bruising needs urgent assessment.

Nefazodone and certain antiviral combinations are contraindicated; ask the pharmacist to check the exact products. Related-drug allergies also need review.

Do not use this product after a known allergy to its active medicine or ingredients; tell the pharmacist about previous medication reactions.

What side effects should I know about?

  • Dizziness, sedation, nausea, double vision and poor coordination.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • Boxed warnings cover potentially fatal skin reactions and serious loss of blood cells. A negative genetic test does not rule out every severe reaction.
  • Stop the medicine and seek urgent assessment for a new rash unless a clinician has established another cause. Blistering, mouth sores, fever with swollen glands, jaundice or unusual bleeding needs urgent care. Severe confusion or seizures can reflect low sodium. Seek emergency care for a seizure, collapse, serious breathing difficulty, facial or throat swelling, or suspected overdose.
  • Contact the prescriber promptly for new suicidal thoughts, worsening depression or unusual behavior. Use emergency care if there is immediate danger or the person cannot stay safe.

What else should I know to stay safe?

  • Pretreatment genetic testing is indicated for some ancestry-related skin-reaction risks. Check blood counts and liver function before treatment, then monitor sodium, symptoms and drug levels when needed. Bone-marrow suppression, relevant drug allergy or recent MAOI treatment can rule out use.
  • Extensive interactions include contraindicated combinations with nefazodone and certain antivirals. Hormonal contraception may become less effective; discuss additional or alternative protection. Avoid grapefruit and alcohol, and discuss pregnancy or breastfeeding.
  • Do not stop abruptly or restart after a substantial interruption without advice because seizure risk and safe dosing can change. Carbamazepine suspension must not be mixed or simultaneously administered with other liquid medicines or diluents. Tegretol suspension contains propylene glycol, an ingredient that can be harmful at excessive exposure. Children under 5 need particular assessment; clinicians should count exposure from other medicines too.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • A genetic test can identify some people at increased risk of a dangerous skin reaction. A negative result cannot rule out every serious rash.
  • Carbamazepine can change how the body handles many medicines, including hormonal contraception. Every new prescription or supplement deserves an interaction check.

How does it work?

Carbamazepine reduces rapid, repeated electrical activity in nerve cells, partly by affecting sodium channels that help carry electrical signals. This helps explain its antiseizure activity, while the way it improves bipolar mania is less clear.

Explore medication science

How was this medicine developed?

Tegretol tablets received FDA approval in 1968. Equetro, a later extended-release capsule approved in 2004, has an acute bipolar I mania or mixed-episode indication as well as other labeled uses.

How do I say the name?

Carbamazepine: kar-ba-MAZ-e-peen. Capital letters show the stressed syllable.

Medicine forms and official information

Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Carbamazepine: current prescribing information — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: 12.1 Mechanism of Action; 12.3 Pharmacokinetics..

  2. Carbamazepine: FDA approval history
  3. Carbamazepine: patient medicine information
  4. Tegretol and Tegretol-XR prescribing information
  5. Tegretol FDA approval history
  6. TEGRETOL
  7. Carbamazepine: Package Insert / Prescribing Info / MOA
  8. DailyMed - CARBAMAZEPINE tablet
  9. Carbamazepine: FDA prescribing information
  10. Oxcarbazepine: prescribing information
  11. Carbamazepine: verified neutral parent, PubChem CID 2554
  12. McLean and Macdonald: Carbamazepine and its epoxide limit rapidly firing action potentials — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: Abstract: cultured mouse neurons and sodium-dependent action potentials..

  13. ISMP List of Confused Drug Names
  14. ISMP List of High-Alert Medications in Community/Ambulatory Care Settings
  15. Frequently Asked Questions about Labeling for Prescription Medicines | FDA

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top